Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.7600
-0.1673 (-18.04%)
At close: Apr 1, 2025, 4:00 PM
0.8894
+0.1294 (17.03%)
After-hours: Apr 1, 2025, 5:07 PM EDT

Estrella Immunopharma Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Jun '24 Jun '23 Jun '22 Jun '21
Selling, General & Admin
3.143.20.660.30.28
Research & Development
5.724.1110.451.390.46
Operating Expenses
8.857.3111.111.690.73
Operating Income
-8.85-7.31-11.11-1.69-0.73
Pretax Income
-8.85-7.31-11.11-1.69-0.73
Income Tax Expense
00---
Net Income
-8.85-7.31-11.11-1.69-0.73
Preferred Dividends & Other Adjustments
----0.61-
Net Income to Common
-8.85-7.31-11.11-1.07-0.73
Shares Outstanding (Basic)
37270--
Shares Outstanding (Diluted)
37270--
Shares Change (YoY)
255.55%8764.81%---
EPS (Basic)
-0.24-0.27-36.35--
EPS (Diluted)
-0.24-0.27-36.35--
EBIT
-8.85-7.31-11.11-1.69-0.73
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q